Ovarian cancer differential diagnosis: Difference between revisions

	Ovarian cancer Microchapters
Home
Patient Information
Overview
Historical Perspective
Classifications
Pathophysiology
Causes of Ovarian cancer
Differentiating Ovarian cancer from other Diseases
Epidemiology & Demographics
Risk Factors
Screening
Natural History, Complications & Prognosis
Diagnosis
History & Symptoms
Physical Examination
Staging
Laboratory Findings
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Ovarian cancer differential diagnosis On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Ovarian cancer differential diagnosis All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Ovarian cancer differential diagnosis
CDC on Ovarian cancer differential diagnosis
Ovarian cancer differential diagnosis in the news
Blogs on Ovarian cancer differential diagnosis
Directions to Hospitals Treating Ovarian cancer
Risk calculators and risk factors for Ovarian cancer differential diagnosis

← Older edit Newer edit →

VisualWikitext

Revision as of 20:26, 24 January 2019

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.

Overview

Differentiating [Disease name] from other Diseases

				Symptoms			Physical examination			Lab Findings	Imaging		Immunohistopathology
Diseases		Clinical manifestations								Para-clinical findings				Gold standard	Additional findings
		Specific risk factors	Age of onset	Symptoms			Physical examination			Para-clinical findings
				pelvic pain or pressure	vaginal discharge	GI dysturbance	Pleural effusion	Fever	Tendernes	Lab Findings	CT scan/US	MRI	Immunohistopathology
Gynecologic
Ovarian	Follicular cysts														It is associated with hyperestrogenism and endometrial hyperplasia
	corpus luteum cysts											Bilateral Multiple			It is associated with hydatidiform moles and choriocarcinoma
	Serous cystadenoma/carcinoma	>55 y/o										Bilateral			Most common ovarian neoplasm
	Mucinous cystadenoma/carcinoma	>55 y/o													Can cause pseudomyxoma peritonei
	Endometrioma			+								Complex mass on US			Infertility
	Teratoma	10-30 y/o
	Dysgerminoma
	Choriocarcinoma
	Yolk sac tumor
	Fibroma
	Thecoma
	Granulosa cell tumor
	Sertoli-leydig cell tumor
	Brenner tumor
	Metastasis (krukenberg)
Tubal	tubo-ovarian abscess														fever and vaginal discharge
	Ectopic pregnancy
	Hydrosalpinx														infertility
	Tuberculosis salpingitis
	Epithelial carcinoma
	serous tubal intraepithelial neoplasm
Uterine	Myoma
	Sarcoma
	Pregnancy
Non-gynecologic
GIT	Appendiceal abscess
	Appendiceal neoplasm
	Diverticular abscess
	GI neoplasm														abdominal pain Intestinal obstruction and bleeding in small bowel,
Renal	Pelvic kidney														tract infection (UTI), obstruction, and renal calculi.
Others	Retroperitoneal sarcoma														Gastrointestinal symptoms, such as early satiety, obstruction,lower extremity edema, Serous ascites

check sites of cancer that may metastasize to the ovaries (eg, stomach, colorectal, breast)

check rectum, liver, spleen, lungs, inguinal or supraclavicular lymph nodes for ovary metastase

References

Template:WH Template:WS

@@ Line 51: / Line 51: @@
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
+* It is associated with hyperestrogenism and endometrial hyperplasia
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Ovarian cyst|corpus luteum cysts]]
@@ Line 64: / Line 65: @@
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
+* Bilateral
+* Multiple
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
+* It is associated with hydatidiform moles and choriocarcinoma
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |Serous cystadenoma/carcinoma
+| style="background: #F5F5F5; padding: 5px;" |>55 y/o
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 79: / Line 84: @@
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
+* Bilateral
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
+* Most common ovarian neoplasm
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Mucinous cystadenoma]]/carcinoma
+| style="background: #F5F5F5; padding: 5px;" |>55 y/o
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 98: / Line 105: @@
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
+* Can cause pseudomyxoma peritonei
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Endometrioma]]
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
+| style="background: #F5F5F5; padding: 5px;" |+
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 111: / Line 119: @@
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
+* Complex mass on US
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |infertility
+* Infertility
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Teratoma]]
-| style="background: #F5F5F5; padding: 5px;" |
+| style="background: #F5F5F5; padding: 5px;" |10-30 y/o
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |

Ovarian cancer differential diagnosis: Difference between revisions

Revision as of 20:26, 24 January 2019

Overview

Differentiating [Disease name] from other Diseases

References

Navigation menu

Search